Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Nicolai Leuchten"'
Autor:
Martin Aringer, Nicolai Leuchten, Babett Heschel, Martyna Hempel, Erik Klapproth, Ali El-Amouche
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss Suppl 2 (2024)
Externí odkaz:
https://doaj.org/article/da49f149c56f40cb9dd4121c0450367c
Autor:
Martin Aringer, Nicolai Leuchten, Adelheid Korb-Pap, Babett Heschel, Annika Krause, Martyna Hempel, Erik Klapproth, Ali El-Amouche
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss Suppl 1 (2024)
Externí odkaz:
https://doaj.org/article/392d8230f84b4b15b88e3ceb41b54386
Publikováno v:
RMD Open, Vol 10, Iss 1 (2024)
Objectives To explore the toxicity of low-dose methotrexate (MTX), an uncommon, but life-threatening event.Methods We analysed the presentation, course and risk factors of all patients admitted to the rheumatology ward with severe low-dose MTX toxici
Externí odkaz:
https://doaj.org/article/148cd26e87cb46b2af0c0a60dcd22c58
Autor:
Martin Aringer, Nicolai Leuchten
Publikováno v:
Zeitschrift für Rheumatologie.
Publikováno v:
Rheumatology. 61:1997-2005
Objective To investigate the relationship between real life glucocorticoid (GC) dosing and relapse rates in patients with new onset GCA in a single centre. Methods Complete clinical data taken from the inpatient and outpatient records of consecutive
Autor:
Julia Körholz, Anastasia Gabrielyan, Henrike Lisa Sczakiel, Livia Schulze, Manuela Rejzek, Martin W Laass, Nicolai Leuchten, Oliver Tiebel, Diana Aust, Karsten Conrad, Nadja Röber, Eva-Maria Jacobsen, Nadja Ehmke, Reinhard Berner, Nadja Lucas, Minae A Lee-Kirsch, Ralf Wiedemuth, Joachim Roesler, Axel Roers, Timm Amendt, Catharina Schuetz
Publikováno v:
Rheumatology (Oxford, England).
Objectives Inborn errors of immunity manifest with susceptibility to infection but may also present with immune dysregulation only. According to the European Society for Immunodeficiencies Registry about 50% of inborn errors of immunity are classifie
Publikováno v:
Zeitschrift für Rheumatologie. 79:232-240
Gezielte Therapie ist ein rheumatologischer Traum, der mit den Biologika und zuletzt kleinen Molekulen fur die rheumatoide Arthritis wahr geworden ist – und fur den systemischen Lupus erythematodes (SLE) beginnt, wahr zu werden. Mit Belimumab steht
Publikováno v:
Kompass Autoimmun. 2:45-52
Das Treat-to-target-Prinzip, bei dem die entzündliche Krankheitsaktivität mithilfe von krankheitsmodifizierenden Arzneimitteln (disease modifying anti-rheumatic drugs, DMARDs) oder Immunsuppressiva unter Kontrolle gebracht wird, ist auch für den s
Publikováno v:
Abstracts.
Autor:
Carlos Vasconcelos, Zahi Touma, Elena Massarotti, Chiara Tani, Ivan Padjen, Gabriela Schmajuk, Ricard Cervera, Guillermo Ruiz-Irastorza, Matthias Schneider, Florence Assan, Edward M Vital, Bernadett Halda-Kiss, Pier Luigi Meroni, Marvin J. Fritzler, Georg Stummvoll, Murray B. Urowitz, Diane L. Kamen, Dinesh Khanna, Maria G Tektonidou, Falk Hiepe, Raphaèle Seror, Søren Jacobsen, Michelle Jung, Marta Mosca, Sule Yavuz, László Czirják, Winfried Graninger, Sara K. Tedeschi, Bimba F. Hoyer, David I. Daikh, Bevra H. Hahn, Karen H. Costenbader, Rosalind Ramsey-Goldman, David Wofsy, Sindhu R. Johnson, Ann E. Clarke, Joseph M. McCune, Nicolai Leuchten, Kirsten Lerstrøm, Yoshiya Tanaka, Betty Diamond, David Jayne, Peter M. Izmirly, Josef S Smolen, George Bertsias, Ralph Brinks, Dimitrios T. Boumpas, Ray Naden, Juanita Romero-Diaz, Mary K. Crow, Gábor Kumánovics, Iñigo Rúa-Figueroa, Daniel J. Wallace, Thomas Dörner, José M. Pego-Reigosa, Jorge Sanchez-Guerrero, Martin Aringer, Xavier Mariette, Branimir Anić, Sarfaraz Hasni, Andrea Doria, Dafna D. Gladman, Nathalie Costedoat-Chalumeau, Tak Mao Chan
Background/objectives The European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) 2019 classification criteria for systemic lupus erythematosus system showed high specificity, while attaining also high sensitivity. We hereby
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36f98e992d9fd0393b4bc63207dc6ba6